BCAL Diagnostics Limited

Company Profile

Sector

Healthcare

Industry

Diagnostics & Research

Employees

N/A

Website

www.bcaldiagnostics.com

Country

Australia

Exchange

ASX

Sydney, Australia

BCAL Diagnostics Limited, a screening and diagnostic company develops a novel blood screening test to improve the diagnosis and monitoring of breast cancer. It develops BREASTESTplus, a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screening. It also develops BREASTEST, BCAL Diagnostics, and BCAL Dx. Incorporated in 2010, the company is headquartered in Sydney, Australia.

Key Stats

52-Week Range

A$0.05A$0.15

Beta0.82

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-0.02

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.